Q1 2023 Holdings
Filed 2023-05-15 | 16 holdings | $738.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc.(KYMR) | Common Stock | 501575104 | $173.6M | 5,858,262 | 23.5% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $113.9M | 9,885,449 | 15.4% |
| Day One Biopharmaceuticals, Inc.(DAWN) | Common Stock | 23954D109 | $101.7M | 7,608,394 | 13.8% |
| Disc Medicine, Inc.(IRON) | Common Stock | 254604101 | $73.4M | 3,461,784 | 9.9% |
| Vigil Neuroscience, Inc.(VIGL) | Common Stock | 92673K108 | $57.1M | 5,836,874 | 7.7% |
| Third Harmonic Bio, Inc.(THRD) | Common Stock | 88427A107 | $44.9M | 10,907,859 | 6.1% |
| Aerovate Therapeutics, Inc. | Common Stock | 008064107 | $41.1M | 2,039,249 | 5.6% |
| Replimune Group, Inc.(REPL) | Common Stock | 76029N106 | $37.1M | 2,098,300 | 5.0% |
| Generation Bio, Co.(GBIOGBX) | Common Stock | 37148K100 | $35.6M | 8,279,484 | 4.8% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $22.7M | 594,251 | 3.1% |
| Ikena Oncology, Inc. | Common Stock | 45175G108 | $17.3M | 5,018,178 | 2.3% |
| Xilio Therapeutics, Inc.(XLO) | Common Stock | 98422T100 | $8.7M | 2,759,344 | 1.2% |
| AvroBio, Inc. | Common Stock | 05455M100 | $4.5M | 4,541,381 | 0.6% |
| Magenta Therapeutics, Inc. | Common Stock | 55910K108 | $3.0M | 3,791,698 | 0.4% |
| Viridian Therapeutics, Inc.(VRDN) | Common Stock | 92790C104 | $2.3M | 90,072 | 0.3% |
| Spero Therapeutics, Inc.(SPRO) | Common Stock | 84833T103 | $1.5M | 1,031,160 | 0.2% |